- Home
- EYPT vs WABC Comparison
EYPT vs WABC Comparison
Compare EYPT & WABC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EYPT | WABC |
|---|---|---|
| Founded | 1987 | 1972 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Major Banks |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.3B |
| IPO Year | 2005 | 1994 |
Fundamental Metrics
Financial Performance| Metric | EYPT | WABC |
|---|---|---|
| Price | $13.36 | $55.30 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 2 |
| Target Price | $31.80 | ★ $54.00 |
| AVG Volume (30 Days) | ★ 786.6K | 151.9K |
| Earning Date | 05-06-2026 | 04-16-2026 |
| Dividend Yield | N/A | ★ 3.35% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 3.40 |
| Revenue | ★ $7,539,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3,115.57 | N/A |
| P/E Ratio | ★ N/A | $16.12 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.46 | $44.93 |
| 52 Week High | $19.11 | $56.22 |
Technical Indicators
Market Signals| Indicator | EYPT | WABC |
|---|---|---|
| Relative Strength Index (RSI) | 43.22 | 67.54 |
| Support Level | $12.47 | $46.47 |
| Resistance Level | $13.32 | $56.22 |
| Average True Range (ATR) | 0.63 | 1.42 |
| MACD | -0.11 | 0.06 |
| Stochastic Oscillator | 27.50 | 81.57 |
Price Performance
Historical ComparisonAbout EYPT EyePoint Pharmaceuticals Inc.
EyePoint Inc focuses is a clinical-stage biopharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, that may reduce the frequency of follow-up care. The company's pipeline program includes i) DURAVYU: a sustained-release product candidate for retinal diseases, with the potential to provide patients with improved visual outcomes with less burden. ii) EYP-2301: early-stage program using Durasert E technology to deliver razuprotafib, a TIE-2 agonist targeting VE-PTP for vascular stability in retinal diseases like wet AMD.
About WABC Westamerica Bancorporation
Westamerica Bancorp is based in San Rafael, California. Westamerica Bancorporation runs a regional community bank and has approximately $7.5 billion in assets. The banks' net revenue is generated by net interest income. Deposit service charges make up the noninterest income sources. The bank focuses mostly on commercial clients, such as smaller businesses. Its footprint encompasses central and northern California, extending north of San Francisco to Mendocino and Lake counties, south to Kern County in central California and all the way east to Nevada County.